Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Sep 01
 -17.08 / -3.33%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 607.00, with a high estimate of 720.00 and a low estimate of 500.00. The median estimate represents a +22.28% increase from the last price of 496.42.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.66%
Growthannually 22.34%


Growthquarterly 5.44%
Growthannually 43.43%
Key to the earnings and sales forecast charts.